Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Prism Medico and Pharmacy Ltd (NSE: PRISMMEDI), ISIN INE730E01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
PRISMMEDI last traded at ₹36.28 (+3.66%), with a 52-week range of ₹15.51 to ₹37.88 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 29.98%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 46/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.